Literature DB >> 31751471

Using a machine learning algorithm to predict acute graft-versus-host disease following allogeneic transplantation.

Yasuyuki Arai1,2, Tadakazu Kondo2, Kyoko Fuse3, Yasuhiko Shibasaki3, Masayoshi Masuko3, Junichi Sugita4, Takanori Teshima4, Naoyuki Uchida5, Takahiro Fukuda6, Kazuhiko Kakihana7, Yukiyasu Ozawa8, Tetsuya Eto9, Masatsugu Tanaka10, Kazuhiro Ikegame11, Takehiko Mori12, Koji Iwato13, Tatsuo Ichinohe14, Yoshinobu Kanda15, Yoshiko Atsuta16,17.   

Abstract

Acute graft-versus-host disease (aGVHD) is 1 of the critical complications that often occurs following allogeneic hematopoietic stem cell transplantation (HSCT). Thus far, various types of prediction scores have been created using statistical calculations. The primary objective of this study was to establish and validate the machine learning-dependent index for predicting aGVHD. This was a retrospective cohort study that involved analyzing databases of adult HSCT patients in Japan. The alternating decision tree (ADTree) machine learning algorithm was applied to develop models using the training cohort (70%). The ADTree algorithm was confirmed using the hazard model on data from the validation cohort (30%). Data from 26 695 HSCT patients transplanted from allogeneic donors between 1992 and 2016 were included in this study. The cumulative incidence of aGVHD was 42.8%. Of >40 variables considered, 15 were adapted into a model for aGVHD prediction. The model was tested in the validation cohort, and the incidence of aGVHD was clearly stratified according to the categorized ADTree scores; the cumulative incidence of aGVHD was 29.0% for low risk and 58.7% for high risk (hazard ratio, 2.57). Predicting scores for aGVHD also demonstrated the link between the risk of development aGVHD and overall survival after HSCT. The machine learning algorithms produced clinically reasonable and robust risk stratification scores. The relatively high reproducibility and low impacts from the interactions among the variables indicate that the ADTree algorithm, along with the other data-mining approaches, may provide tools for establishing risk score.
© 2019 by The American Society of Hematology.

Entities:  

Year:  2019        PMID: 31751471      PMCID: PMC6880900          DOI: 10.1182/bloodadvances.2019000934

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  25 in total

1.  Big data analytics and machine learning: 2015 and beyond.

Authors:  Ives Cavalcante Passos; Benson Mwangi; Flávio Kapczinski
Journal:  Lancet Psychiatry       Date:  2016-01       Impact factor: 27.083

Review 2.  Application of machine learning algorithms for clinical predictive modeling: a data-mining approach in SCT.

Authors:  R Shouval; O Bondi; H Mishan; A Shimoni; R Unger; A Nagler
Journal:  Bone Marrow Transplant       Date:  2013-10-07       Impact factor: 5.483

3.  Serum neutrophil extracellular trap levels predict thrombotic microangiopathy after allogeneic stem cell transplantation.

Authors:  Yasuyuki Arai; Kouhei Yamashita; Kiyomi Mizugishi; Tomohiro Watanabe; Soichiro Sakamoto; Toshiyuki Kitano; Tadakazu Kondo; Hiroshi Kawabata; Norimitsu Kadowaki; Akifumi Takaori-Kondo
Journal:  Biol Blood Marrow Transplant       Date:  2013-09-19       Impact factor: 5.742

Review 4.  Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation.

Authors:  Simona Iacobelli
Journal:  Bone Marrow Transplant       Date:  2013-03       Impact factor: 5.483

5.  Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System.

Authors:  Yoshiko Atsuta; Ritsuro Suzuki; Ayami Yoshimi; Hisashi Gondo; Junji Tanaka; Akira Hiraoka; Koji Kato; Ken Tabuchi; Masahiro Tsuchida; Yasuo Morishima; Makoto Mitamura; Keisei Kawa; Shunichi Kato; Tokiko Nagamura; Minoko Takanashi; Yoshihisa Kodera
Journal:  Int J Hematol       Date:  2007-10       Impact factor: 2.490

6.  Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation.

Authors:  Y Arai; J Kanda; H Nakasone; T Kondo; N Uchida; T Fukuda; K Ohashi; K Kaida; K Iwato; T Eto; Y Kanda; H Nakamae; T Nagamura-Inoue; Y Morishima; M Hirokawa; Y Atsuta; M Murata
Journal:  Bone Marrow Transplant       Date:  2015-09-14       Impact factor: 5.483

7.  High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.

Authors:  Stephanie J Lee; John Klein; Michael Haagenson; Lee Ann Baxter-Lowe; Dennis L Confer; Mary Eapen; Marcelo Fernandez-Vina; Neal Flomenberg; Mary Horowitz; Carolyn K Hurley; Harriet Noreen; Machteld Oudshoorn; Effie Petersdorf; Michelle Setterholm; Stephen Spellman; Daniel Weisdorf; Thomas M Williams; Claudio Anasetti
Journal:  Blood       Date:  2007-09-04       Impact factor: 22.113

8.  Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement.

Authors:  Gary S Collins; Johannes B Reitsma; Douglas G Altman; Karel G M Moons
Journal:  BMC Med       Date:  2015-01-06       Impact factor: 8.775

9.  Patient-based prediction algorithm of relapse after allo-HSCT for acute Leukemia and its usefulness in the decision-making process using a machine learning approach.

Authors:  Kyoko Fuse; Shun Uemura; Suguru Tamura; Tatsuya Suwabe; Takayuki Katagiri; Tomoyuki Tanaka; Takashi Ushiki; Yasuhiko Shibasaki; Naoko Sato; Toshio Yano; Takashi Kuroha; Shigeo Hashimoto; Tatsuo Furukawa; Miwako Narita; Hirohito Sone; Masayoshi Masuko
Journal:  Cancer Med       Date:  2019-07-15       Impact factor: 4.452

10.  Clinical significance of high-dose cytarabine added to cyclophosphamide/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancy.

Authors:  Yasuyuki Arai; Kazunari Aoki; June Takeda; Tadakazu Kondo; Tetsuya Eto; Shuichi Ota; Hisako Hashimoto; Takahiro Fukuda; Yukiyasu Ozawa; Yoshinobu Kanda; Chiaki Kato; Mineo Kurokawa; Koji Iwato; Makoto Onizuka; Tatsuo Ichinohe; Yoshiko Atsuta; Akiyoshi Takami
Journal:  J Hematol Oncol       Date:  2015-09-04       Impact factor: 17.388

View more
  11 in total

Review 1.  Application of machine learning in the management of acute myeloid leukemia: current practice and future prospects.

Authors:  Jan-Niklas Eckardt; Martin Bornhäuser; Karsten Wendt; Jan Moritz Middeke
Journal:  Blood Adv       Date:  2020-12-08

2.  Prediction and recommendation by machine learning through repetitive internal validation for hepatic veno-occlusive disease/sinusoidal obstruction syndrome and early death after allogeneic hematopoietic cell transplantation.

Authors:  Seungjoon Lee; Eunsaem Lee; Sung-Soo Park; Min Sue Park; Jaewoo Jung; Gi June Min; Silvia Park; Sung-Eun Lee; Byung-Sik Cho; Ki-Seong Eom; Yoo-Jin Kim; Seok Lee; Hee-Je Kim; Chang-Ki Min; Seok-Goo Cho; Jong Wook Lee; Hyung Ju Hwang; Jae-Ho Yoon
Journal:  Bone Marrow Transplant       Date:  2022-01-24       Impact factor: 5.483

3.  Predicting Long-term Survival After Allogeneic Hematopoietic Cell Transplantation in Patients With Hematologic Malignancies: Machine Learning-Based Model Development and Validation.

Authors:  Eun-Ji Choi; Tae Joon Jun; Han-Seung Park; Jung-Hee Lee; Kyoo-Hyung Lee; Young-Hak Kim; Young-Shin Lee; Young-Ah Kang; Mijin Jeon; Hyeran Kang; Jimin Woo; Je-Hwan Lee
Journal:  JMIR Med Inform       Date:  2022-03-07

4.  Machine learning-based scoring models to predict hematopoietic stem cell mobilization in allogeneic donors.

Authors:  Jingyu Xiang; Min Shi; Mark A Fiala; Feng Gao; Michael P Rettig; Geoffrey L Uy; Mark A Schroeder; Katherine N Weilbaecher; Keith E Stockerl-Goldstein; Shamim Mollah; John F DiPersio
Journal:  Blood Adv       Date:  2022-04-12

5.  Establishment of a predictive model for GVHD-free, relapse-free survival after allogeneic HSCT using ensemble learning.

Authors:  Makoto Iwasaki; Junya Kanda; Yasuyuki Arai; Tadakazu Kondo; Takayuki Ishikawa; Yasunori Ueda; Kazunori Imada; Takashi Akasaka; Akihito Yonezawa; Kazuhiro Yago; Masaharu Nohgawa; Naoyuki Anzai; Toshinori Moriguchi; Toshiyuki Kitano; Mitsuru Itoh; Nobuyoshi Arima; Tomoharu Takeoka; Mitsumasa Watanabe; Hirokazu Hirata; Kosuke Asagoe; Isao Miyatsuka; Le My An; Masanori Miyanishi; Akifumi Takaori-Kondo
Journal:  Blood Adv       Date:  2022-04-26

Review 6.  A Review of Artificial Intelligence Applications in Hematology Management: Current Practices and Future Prospects.

Authors:  Yousra El Alaoui; Adel Elomri; Marwa Qaraqe; Regina Padmanabhan; Ruba Yasin Taha; Halima El Omri; Abdelfatteh El Omri; Omar Aboumarzouk
Journal:  J Med Internet Res       Date:  2022-07-12       Impact factor: 7.076

Review 7.  Biomarkers for Allogeneic HCT Outcomes.

Authors:  Djamilatou Adom; Courtney Rowan; Titilayo Adeniyan; Jinfeng Yang; Sophie Paczesny
Journal:  Front Immunol       Date:  2020-04-21       Impact factor: 7.561

8.  Predicting Acute Graft-Versus-Host Disease Using Machine Learning and Longitudinal Vital Sign Data From Electronic Health Records.

Authors:  Shengpu Tang; Grant T Chappell; Amanda Mazzoli; Muneesh Tewari; Sung Won Choi; Jenna Wiens
Journal:  JCO Clin Cancer Inform       Date:  2020-02

Review 9.  A Systematic Review of Machine Learning Techniques in Hematopoietic Stem Cell Transplantation (HSCT).

Authors:  Vibhuti Gupta; Thomas M Braun; Mosharaf Chowdhury; Muneesh Tewari; Sung Won Choi
Journal:  Sensors (Basel)       Date:  2020-10-27       Impact factor: 3.576

10.  An Intelligent Clinical Decision Support System for Predicting Acute Graft-versus-host Disease (aGvHD) following Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Cirruse Salehnasab; Abbas Hajifathali; Farkhondeh Asadi; Sayeh Parkhideh; Alireza Kazemi; Arash Roshanpoor; Mahshid Mehdizadeh; Maria Tavakoli-Ardakani; Elham Roshandel
Journal:  J Biomed Phys Eng       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.